These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1065 related items for PubMed ID: 1531129

  • 21. Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor.
    Sybertz EJ, Chiu PJ, Vemulapalli S, Watkins R, Haslanger MF.
    Hypertension; 1990 Feb; 15(2):152-61. PubMed ID: 2154404
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.
    Kinnunen P, Vuolteenaho O, Ruskoaho H.
    Endocrinology; 1993 May; 132(5):1961-70. PubMed ID: 8477647
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR, Settle SL, Kirk JE, Taylor SA, Moore KP, Unwin RJ.
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [Abstract] [Full Text] [Related]

  • 27. Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat.
    Zukowska-Grojec Z, Haass M, Kopin IJ, Zamir N.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):480-7. PubMed ID: 2877083
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats.
    Koepke JP, Tyler LD, Trapani AJ, Bovy PR, Spear KL, Olins GM, Blaine EH.
    J Pharmacol Exp Ther; 1989 Apr; 249(1):172-6. PubMed ID: 2565386
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers.
    Burnier M, Ganslmayer M, Perret F, Porchet M, Kosoglou T, Gould A, Nussberger J, Waeber B, Brunner HR.
    Clin Pharmacol Ther; 1991 Aug; 50(2):181-91. PubMed ID: 1831083
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Neither ventricles nor afterload relief influence the raised plasma atrial natriuretic factor induced by volume expansion in the spontaneously hypertensive rat.
    Lachance D, Garcia R.
    Cardiovasc Res; 1991 Jun; 25(6):475-83. PubMed ID: 1832333
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Natriuretic and diuretic effects of infusion of atrial natriuretic factor in conscious dogs.
    Ohanian J, Young MA, Shen YT, Gaivin R, Vatner SF, Graham RM.
    Am J Physiol; 1989 Oct; 257(4 Pt 2):F565-73. PubMed ID: 2529778
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.